Short Communication - (2025) Volume 11, Issue 1
Received: 03-Feb-2025, Manuscript No. jcrdc-25-172047;
Editor assigned: 05-Feb-2025, Pre QC No. P-172047;
Reviewed: 19-Feb-2025, QC No. Q-172047;
Revised: 24-Feb-2025, Manuscript No. R-172047;
Published:
28-Feb-2025
, DOI: 10.37421/2472-1247.2025.11.355
Citation: Nkosi, Thabo. ”Advanced Mechanical Ventilation for Acute Respiratory Failure.” J Clin Respir Dis Care11 (2025):355.
Copyright: © 2025 Nkosi T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution
and reproduction in any medium, provided the original author and source are credited.
This review highlights the critical components of lung-protective ventilation in ARDS, emphasizing low tidal volumes and appropriate PEEP to minimize ventilator-induced lung injury. It discusses the evolving understanding of how mechanical forces impact the lung and the ongoing challenges in individualizing these strategies for optimal patient outcomes. The focus is on preventing further lung damage while maintaining adequate gas exchange[1].
This systematic review examines various predictors used to assess readiness for weaning from mechanical ventilation. It consolidates evidence on respiratory mechanics, gas exchange, and patient-specific factors, identifying the most reliable indicators for successful extubation and highlighting areas where more robust predictive tools are needed to reduce reintubation rates[2].
This article delves into the various types of patient-ventilator asynchrony, their causes, and their significant clinical impact on patient comfort, outcomes, and the duration of mechanical ventilation. It outlines diagnostic approaches and therapeutic strategies, including ventilator settings adjustments and pharmacologic interventions, to optimize synchrony and minimize harm[3].
This review details the role of extracorporeal membrane oxygenation (ECMO) in managing severe acute respiratory distress syndrome (ARDS), particularly when conventional mechanical ventilation fails. It covers patient selection criteria, technical considerations, and the importance of a multidisciplinary approach to optimize outcomes while balancing the risks associated with this advanced life support modality[4].
This article provides an overview of the use of neuromuscular blocking agents (NMBAs) in patients with ARDS requiring mechanical ventilation. It discusses the rationale for their use, primarily to improve patient-ventilator synchrony and reduce lung injury in early severe ARDS, while also addressing the potential adverse effects and the need for careful patient selection and monitoring[5].
This review discusses the persistent diagnostic and therapeutic challenges associated with ventilator-associated pneumonia (VAP), a significant complication of mechanical ventilation. It explores the complexities in reliably diagnosing VAP, the impact of antimicrobial resistance, and strategies for optimizing empirical and targeted antimicrobial therapies to improve patient outcomes[6].
This narrative review explores the current evidence and applications of non-invasive ventilation (NIV) in various etiologies of acute respiratory failure in critically ill patients. It discusses patient selection, ventilator settings, and predictors of NIV success or failure, emphasizing its role in avoiding invasive mechanical ventilation in appropriate candidates while highlighting scenarios where its use can be detrimental[7].
This review explores the utility of advanced imaging techniques, such as computed tomography (CT) and electrical impedance tomography (EIT), in tailoring mechanical ventilation strategies for individual patients. It highlights how these modalities can provide crucial insights into regional lung mechanics, recruitability, and overdistension, enabling clinicians to optimize PEEP and tidal volume settings to minimize ventilator-induced lung injury[8].
This review synthesizes the current evidence on the use of high-flow nasal cannula (HFNC) therapy in patients with acute respiratory failure. It discusses its physiological mechanisms, clinical benefits in various patient populations, and its role as an alternative or bridge to mechanical ventilation, emphasizing the importance of patient selection and careful monitoring to prevent intubation failure[9].
This article explores the concept of mechanical power as a comprehensive measure of the energy transmitted to the lungs during mechanical ventilation, linking it to the development of ventilator-induced lung injury (VILI) in ARDS. It discusses how mechanical power integrates various ventilatory parameters, including tidal volume, respiratory rate, and driving pressure, providing a holistic approach to optimizing ventilation settings to minimize lung damage[10].
This review highlights the critical components of lung-protective ventilation in ARDS, emphasizing low tidal volumes and appropriate PEEP to minimize ventilator-induced lung injury. It discusses the evolving understanding of how mechanical forces impact the lung and the ongoing challenges in individualizing these strategies for optimal patient outcomes. The focus is on preventing further lung damage while maintaining adequate gas exchange[1].
This systematic review examines various predictors used to assess readiness for weaning from mechanical ventilation. It consolidates evidence on respiratory mechanics, gas exchange, and patient-specific factors, identifying the most reliable indicators for successful extubation and highlighting areas where more robust predictive tools are needed to reduce reintubation rates[2].
This article delves into the various types of patient-ventilator asynchrony, their causes, and their significant clinical impact on patient comfort, outcomes, and the duration of mechanical ventilation. It outlines diagnostic approaches and therapeutic strategies, including ventilator settings adjustments and pharmacologic interventions, to optimize synchrony and minimize harm[3].
This review details the role of extracorporeal membrane oxygenation (ECMO) in managing severe acute respiratory distress syndrome (ARDS), particularly when conventional mechanical ventilation fails. It covers patient selection criteria, technical considerations, and the importance of a multidisciplinary approach to optimize outcomes while balancing the risks associated with this advanced life support modality[4].
This article provides an overview of the use of neuromuscular blocking agents (NMBAs) in patients with ARDS requiring mechanical ventilation. It discusses the rationale for their use, primarily to improve patient-ventilator synchrony and reduce lung injury in early severe ARDS, while also addressing the potential adverse effects and the need for careful patient selection and monitoring[5].
This review discusses the persistent diagnostic and therapeutic challenges associated with ventilator-associated pneumonia (VAP), a significant complication of mechanical ventilation. It explores the complexities in reliably diagnosing VAP, the impact of antimicrobial resistance, and strategies for optimizing empirical and targeted antimicrobial therapies to improve patient outcomes[6].
This narrative review explores the current evidence and applications of non-invasive ventilation (NIV) in various etiologies of acute respiratory failure in critically ill patients. It discusses patient selection, ventilator settings, and predictors of NIV success or failure, emphasizing its role in avoiding invasive mechanical ventilation in appropriate candidates while highlighting scenarios where its use can be detrimental[7].
This review explores the utility of advanced imaging techniques, such as computed tomography (CT) and electrical impedance tomography (EIT), in tailoring mechanical ventilation strategies for individual patients. It highlights how these modalities can provide crucial insights into regional lung mechanics, recruitability, and overdistension, enabling clinicians to optimize PEEP and tidal volume settings to minimize ventilator-induced lung injury[8].
This review synthesizes the current evidence on the use of high-flow nasal cannula (HFNC) therapy in patients with acute respiratory failure. It discusses its physiological mechanisms, clinical benefits in various patient populations, and its role as an alternative or bridge to mechanical ventilation, emphasizing the importance of patient selection and careful monitoring to prevent intubation failure[9].
This article explores the concept of mechanical power as a comprehensive measure of the energy transmitted to the lungs during mechanical ventilation, linking it to the development of ventilator-induced lung injury (VILI) in ARDS. It discusses how mechanical power integrates various ventilatory parameters, including tidal volume, respiratory rate, and driving pressure, providing a holistic approach to optimizing ventilation settings to minimize lung damage[10].
This collection of articles explores critical aspects of mechanical ventilation, particularly in the context of Acute Respiratory Distress Syndrome (ARDS) and acute respiratory failure. A core theme is lung-protective ventilation, emphasizing low tidal volumes and appropriate Positive End-Expiratory Pressure (PEEP) to mitigate ventilator-induced lung injury, driven by an evolving understanding of mechanical forces and the concept of mechanical power. The process of weaning patients from mechanical ventilation is critically examined, identifying reliable predictors for successful extubation and reducing reintubation rates. Patient-ventilator asynchrony is also highlighted, detailing its causes, clinical impact on patient outcomes, and management strategies to optimize synchrony. Beyond conventional ventilation, advanced life support modalities are discussed. Extracorporeal Membrane Oxygenation (ECMO) is reviewed for severe ARDS when standard ventilation fails, covering selection criteria and the multidisciplinary approach needed. Adjunctive therapies include neuromuscular blocking agents in early severe ARDS to improve synchrony and reduce lung injury. Non-Invasive Ventilation (NIV) and High-Flow Nasal Cannula (HFNC) therapy are explored as means to avoid invasive ventilation, detailing their applications, physiological mechanisms, and patient selection for acute respiratory failure. The reviews also address complications like Ventilator-Associated Pneumonia (VAP), discussing diagnostic challenges and optimizing antimicrobial therapies. Finally, advanced imaging techniques, such as Computed Tomography (CT) and Electrical Impedance Tomography (EIT), are presented for tailoring ventilation strategies by providing insights into regional lung mechanics and optimizing PEEP and tidal volume settings. This body of work collectively aims to enhance patient outcomes, minimize lung damage, and refine management strategies in critically ill patients requiring ventilatory support.
None
None
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
